Mary Martineau

1.6k total citations · 1 hit paper
17 papers, 949 citations indexed

About

Mary Martineau is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Molecular Biology. According to data from OpenAlex, Mary Martineau has authored 17 papers receiving a total of 949 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Public Health, Environmental and Occupational Health, 9 papers in Hematology and 6 papers in Molecular Biology. Recurrent topics in Mary Martineau's work include Acute Lymphoblastic Leukemia research (12 papers), Chronic Myeloid Leukemia Treatments (7 papers) and Genomic variations and chromosomal abnormalities (6 papers). Mary Martineau is often cited by papers focused on Acute Lymphoblastic Leukemia research (12 papers), Chronic Myeloid Leukemia Treatments (7 papers) and Genomic variations and chromosomal abnormalities (6 papers). Mary Martineau collaborates with scholars based in United Kingdom, United States and Czechia. Mary Martineau's co-authors include Christine J. Harrison, Lorna M. Secker‐Walker, Anthony V. Moorman, Letizia Foroni, Sue Richards, Mark R. Litzow, Peter H. Wiernik, Adele K. Fielding, Elisabeth Paietta and Rodney R. Higgins and has published in prestigious journals such as The Lancet, Blood and Cancer Research.

In The Last Decade

Mary Martineau

17 papers receiving 916 citations

Hit Papers

Karyotype is an independent prognostic factor in adult ac... 2006 2026 2012 2019 2006 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial
    2006 502 citations Anthony V. Moorman, Christine J. Harrison et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary Martineau United Kingdom 13 722 622 227 166 120 17 949
R Släter Netherlands 17 543 0.8× 606 1.0× 257 1.1× 395 2.4× 95 0.8× 24 983
ER van Wering Netherlands 12 649 0.9× 719 1.2× 238 1.0× 317 1.9× 123 1.0× 16 1.1k
JR Downing United States 9 434 0.6× 534 0.9× 102 0.4× 331 2.0× 83 0.7× 9 823
LM Secker-Walker United Kingdom 19 734 1.0× 943 1.5× 98 0.4× 372 2.2× 99 0.8× 22 1.2k
Jan Zuna Czechia 21 813 1.1× 739 1.2× 232 1.0× 316 1.9× 155 1.3× 61 1.1k
Silja Röttgers Germany 13 453 0.6× 463 0.7× 166 0.7× 199 1.2× 192 1.6× 14 778
DL Williams United States 16 1.1k 1.5× 1.0k 1.7× 227 1.0× 316 1.9× 138 1.1× 23 1.5k
SP Hunger United States 14 491 0.7× 636 1.0× 94 0.4× 491 3.0× 117 1.0× 21 986
VJ Land United States 12 769 1.1× 664 1.1× 237 1.0× 173 1.0× 74 0.6× 15 916
E. Renate Panzer-Grümayer Austria 14 692 1.0× 614 1.0× 244 1.1× 203 1.2× 149 1.2× 20 1.0k

Countries citing papers authored by Mary Martineau

Since Specialization
Citations

This map shows the geographic impact of Mary Martineau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Martineau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Martineau more than expected).

Fields of papers citing papers by Mary Martineau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Martineau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Martineau. The network helps show where Mary Martineau may publish in the future.

Co-authorship network of co-authors of Mary Martineau

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Martineau. A scholar is included among the top collaborators of Mary Martineau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Martineau. Mary Martineau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Konn, Zoë J., Mary Martineau, Sue Richards, et al.. (2009). Cytogenetics of long‐term survivors of ETV6‐RUNX1 fusion positive acute lymphoblastic leukemia. Genes Chromosomes and Cancer. 49(3). 253–259. 2 indexed citations
2.
Barber, Kerry E., Christine J. Harrison, Adam Stewart, et al.. (2007). Molecular cytogenetic characterization of TCF3 (E2A)/19p13.3 rearrangements in B‐cell precursor acute lymphoblastic leukemia. Genes Chromosomes and Cancer. 46(5). 478–486. 45 indexed citations
3.
Moorman, Anthony V., Christine J. Harrison, Georgina Buck, et al.. (2006). Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial. Blood. 109(8). 3189–3197. 502 indexed citations breakdown →
4.
Harrison, Christine J., Anthony V. Moorman, Kerry E. Barber, et al.. (2005). Interphase molecular cytogenetic screening for chromosomal abnormalities of prognostic significance in childhood acute lymphoblastic leukaemia: a UK Cancer Cytogenetics Group Study. British Journal of Haematology. 129(4). 520–530. 92 indexed citations
5.
Martineau, Mary, G. Reza Jalali, Kerry E. Barber, et al.. (2005). ETV6/RUNX1 fusion at diagnosis and relapse: Some prognostic indications. Genes Chromosomes and Cancer. 43(1). 54–71. 14 indexed citations
6.
Hain, Richard, Christine J. Harrison, G. Reza Jalali, et al.. (2004). Complex chromosomal abnormalities in utero, 5 years before leukaemia*. British Journal of Haematology. 126(3). 307–312. 14 indexed citations
7.
Sinclair, Paul, et al.. (2004). A Fluorescence in Situ Hybridization Map of 6q Deletions in Acute Lymphocytic Leukemia. Cancer Research. 64(12). 4089–4098. 39 indexed citations
8.
Harris, Rachel L., et al.. (2004). Is trisomy 5 a distinct cytogenetic subgroup in acute lymphoblastic leukemia?. Cancer Genetics and Cytogenetics. 148(2). 159–162. 14 indexed citations
9.
Harrison, Christine J., Mary Martineau, & Lorna M. Secker‐Walker. (2001). The Leukaemia Research Fund/United Kingdom Cancer Cytogenetics Group Karyotype Database in acute lymphoblastic leukaemia: a valuable resource for patient management. British Journal of Haematology. 113(1). 3–10. 60 indexed citations
10.
Martineau, Mary, et al.. (1996). Isochromosomes in acute lymphoblastic leukaemia: I(21q) is a significant finding. Genes Chromosomes and Cancer. 17(1). 21–30. 28 indexed citations
11.
Moorman, Anthony V., et al.. (1996). Probes for hidden hyperdiploidy in acute lymphoblastic leukaemia. Genes Chromosomes and Cancer. 16(1). 40–45. 34 indexed citations
12.
Moorman, Anthony V., et al.. (1996). Probes for hidden hyperdiploidy in acute lymphoblastic leukaemia. Genes Chromosomes and Cancer. 16(1). 40–45. 3 indexed citations
13.
Hawkins, Jacqueline, Anthony V. Moorman, A. V. Hoffbrand, et al.. (1994). Association of 17p loss with late-stage or refractory disease in hematologic malignancy. Cancer Genetics and Cytogenetics. 77(2). 134–143. 16 indexed citations
14.
Yamada, Toshiyuki, et al.. (1990). Demonstration of acquired hemizygosity and clonality in acute lymphoblastic leukemia with chromosome 7 abnormalities using hypervariable DNA probes. Genes Chromosomes and Cancer. 2(2). 88–93. 7 indexed citations
15.
Martineau, Mary. (1969). Chromosomes in human testicular tumours. The Journal of Pathology. 99(4). 271–282. 34 indexed citations
16.
Martineau, Mary. (1967). CHROMOSOMES IN TESTICULAR TUMOURS. The Lancet. 289(7486). 386–386. 1 indexed citations
17.
Martineau, Mary. (1966). A SIMILAR MARKER CHROMOSOME IN TESTICULAR TUMOURS. The Lancet. 287(7442). 839–842. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R Släter Breakdown of academic impact, for papers by ER van Wering Breakdown of academic impact, for papers by JR Downing Breakdown of academic impact, for papers by LM Secker-Walker Breakdown of academic impact, for papers by Jan Zuna Breakdown of academic impact, for papers by Silja Röttgers Breakdown of academic impact, for papers by DL Williams Breakdown of academic impact, for papers by SP Hunger Breakdown of academic impact, for papers by VJ Land Breakdown of academic impact, for papers by E. Renate Panzer-Grümayer
Rankless by CCL
2026